ARWR Arrowhead Pharmaceuticals, Inc.
$47.78
Arrowhead Pharmaceuticals, Inc. (ARWR) Earnings News
Earnings press releases, previews and reviews for Arrowhead Pharmaceuticals, Inc. (ARWR), newest first. Our most recent is review: Arrowhead's Deep Fourth-Quarter Miss Collides With an Accelerated SHTG Timeline and Inflecting REDEMPLO Demand.
Thursday
November 12, 2026
6:42 PM ET
Arrowhead's Deep Fourth-Quarter Miss Collides With an Accelerated SHTG Timeline and Inflecting REDEMPLO Demand
Earnings Whispers · Review
Thursday
November 12, 2026
4:01 PM ET
Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results
Wednesday
November 4, 2026
4:40 PM ET
Arrowhead Must Show Redemplo Traction and SHTG Filing Progress After 32% Slide
Earnings Whispers · Preview
Tuesday
November 3, 2026
4:00 PM ET
Arrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results
Tuesday
August 4, 2026
4:01 PM ET
Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results
Tuesday
July 21, 2026
7:30 AM ET
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 Third Quarter Results